239
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Impact of Myocardial Ischemia and Revascularization by Percutaneous Coronary Intervention on Circulating Level of Soluble ST2

, , ORCID Icon, ORCID Icon, ORCID Icon &
Pages 411-420 | Received 07 Apr 2023, Accepted 30 Jun 2023, Published online: 06 Jul 2023

References

  • Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr. 2011;9(1):8. doi:10.1186/1478-7954-9-8
  • Ciccone MM, Cortese F, Gesualdo M, et al. A novel cardiac bio-marker: ST2: a review. Molecules. 2013;18(12):15314–15328. doi:10.3390/molecules181215314
  • Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008;7(10):827–840. doi:10.1038/nrd2660
  • Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation. 2002;106(23):2961–2966. doi:10.1161/01.cir.0000038705.69871.d9
  • Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007;117(6):1538–1549. doi:10.1172/JCI30634
  • Seki K, Sanada S, Kudinova AY, et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail. 2009;2(6):684–691. doi:10.1161/CIRCHEARTFAILURE.109.873240
  • Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239. doi:10.1016/j.jacc.2013.05.019
  • Sweet MJ, Leung BP, Kang D, et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol. 2001;166(11):6633–6639. doi:10.4049/jimmunol.166.11.6633
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
  • Brown AM, Wu AHB, Clopton P, Robey JL, Hollander JE. ST2 in emergency department chest pain patients with potential acute coronary syndromes. Ann Emerg Med. 2007;50(2):153–158.e1. doi:10.1016/j.annemergmed.2007.02.015
  • Aldous SJ, Richards AM, Troughton R, Than M. ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain. J Card Fail. 2012;18(4):304–310. doi:10.1016/j.cardfail.2012.01.008
  • Januzzi JL, Pascual-Figal D, Daniels LB. ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel. Am J Cardiol. 2015;115(7 Suppl):70B–5B. doi:10.1016/j.amjcard.2015.01.044
  • Wu AH, Wians F, Jaffe A. Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results. Am Heart J. 2013;165(6):995–999. doi:10.1016/j.ahj.2013.02.029
  • Alkhateeb A, Abd Elrady NS, Ali AMS, Hashim AKA. Impact of diabetes mellitus on acute and short term left ventricular longitudinal systolic strain recovery after percutaneous coronary intervention in ischemic hypertensive patients. SVU Int J Med Sci. 2023;6(2):152–159. doi:10.21608/svuijm.2023.202042.1556
  • Gensini GG. Coronary Arteriography / by Goffredo G. Gensini Mount Kisco, N.Y: Futura Pub. Co; 1975.
  • Golabchi A, Sadeghi M, Sanei H, et al. Can timi risk score predict angiographic involvement in patients with st-elevation myocardial infarction? ARYA Atheroscler. 2010;6(2):69–73.
  • Coglianese EE, Larson MG, Vasan RS, et al. Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study. Clin Chem. 2012;58(12):1673–1681. doi:10.1373/clinchem.2012.192153
  • Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization [published correction appears in. Eur Heart J. 2019;40(37):3096. doi:10.1093/eurheartj/ehy394
  • Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 1990;119(6):1262–1267. doi:10.1016/s0002-8703(05)80173-5
  • Adams MR, Nakagomi A, Keech A, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995;92(8):2127–2134. doi:10.1161/01.cir.92.8.2127
  • Zhang T, Xu C, Zhao R, Cao Z. Diagnostic Value of sST2 in Cardiovascular Diseases: a Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021;8:697837. doi:10.3389/fcvm.2021.697837
  • Richards AM, Di Somma S, Mueller T. ST2 in stable and unstable ischemic heart diseases. Am J Cardiol. 2015;115(7 Suppl):48B–58B. doi:10.1016/j.amjcard.2015.01.041
  • Crnko S, Printezi MI, Jansen TPJ, et al. Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients. ESC Heart Fail. 2020;7(3):1224–1233. doi:10.1002/ehf2.12673
  • Eggers KM, Armstrong PW, Califf RM, et al. ST2 and mortality in non-ST-segment elevation acute coronary syndrome. Am Heart J. 2010;159(5):788–794. doi:10.1016/j.ahj.2010.02.022
  • Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation. 2004;109(18):2186–2190. doi:10.1161/01.CIR.0000127958.21003.5A
  • Dieplinger B, Egger M, Haltmayer M, et al. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study. Clin Chem. 2014;60(3):530–540. doi:10.1373/clinchem.2013.209858
  • Weir RA, Miller AM, Murphy GE, et al. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol. 2010;55(3):243–250. doi:10.1016/j.jacc.2009.08.047
  • Sabatine MS, Morrow DA, Higgins LJ, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation. 2008;117(15):1936–1944. doi:10.1161/CIRCULATIONAHA.107.728022